{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:04:35Z","timestamp":1781723075954,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008054","name":"Fundacion Ramon Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.exer.2024.109977","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T06:32:51Z","timestamp":1718692371000},"page":"109977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Laboratory exploration of the use of ripasudil in descemetorhexis with a human ex vivo model"],"prefix":"10.1016","volume":"245","author":[{"given":"Meidong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-6164","authenticated-orcid":false,"given":"Barbara","family":"Burgos-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Northey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Spiteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Petsoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2024.109977_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ICO.0000000000002796","article-title":"Descemet stripping only for Fuchs endothelial corneal dystrophy: will it become the gold standard?","volume":"41","author":"Colby","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/ICO.0000000000002421","article-title":"Case series: novel utilization of rho-kinase inhibitor for the treatment of corneal edema","volume":"40","author":"Davies","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/ICO.0000000000002691","article-title":"Pilot study of corneal clearance with the use of a rho-kinase inhibitor after descemetorhexis without endothelial keratoplasty for Fuchs endothelial corneal dystrophy","volume":"40","author":"Davies","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICO.0000000000001427","article-title":"Predictive factors for corneal clearance after descemetorhexis without endothelial keratoplasty","volume":"37","author":"Davies","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib5","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2024.109977_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/ICU.0000000000000579","article-title":"Descemet's stripping without endothelial keratoplasty","volume":"30","author":"Garcerant","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109977_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep19640","article-title":"Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.109977_bib8","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/ICO.0000000000001528","article-title":"Descemetorhexis without endothelial keratoplasty (DWEK): proposal for nomenclature standardization","volume":"37","author":"Kaufman","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/bjophthalmol-2015-307792","article-title":"A comparison of endothelial and penetrating keratoplasty outcomes following failed penetrating keratoplasty: a registry study","volume":"100","author":"Keane","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109977_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/cm.20194","article-title":"Rho plays a central role in regulating local cell-matrix mechanical interactions in 3D culture","volume":"64","author":"Lakshman","year":"2007","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.exer.2024.109977_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","article-title":"Rho kinase (ROCK) inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.exer.2024.109977_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2024.109977_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/ICO.0000000000001883","article-title":"Use of topical Rho kinase inhibitors in the treatment of Fuchs dystrophy after Descemet stripping only","volume":"38","author":"Macsai","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/ICO.0000000000001209","article-title":"Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil","volume":"36","author":"Moloney","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2024.109977_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2646904","article-title":"Application of Rho kinase inhibitors for the treatment of corneal endothelial diseases","volume":"2017","author":"Okumura","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109977_bib16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1167\/iovs.12-11320","article-title":"The ROCK inhibitor eye drop accelerates corneal endothelium wound healing","volume":"54","author":"Okumura","year":"2013","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1167\/iovs.13-12225","article-title":"Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing","volume":"55","author":"Okumura","year":"2014","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1167\/iovs.15-18586","article-title":"Effect of the rho-associated kinase inhibitor eye drop (ripasudil) on corneal endothelial wound healing","volume":"57","author":"Okumura","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib19","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1167\/iovs.08-2634","article-title":"Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor","volume":"50","author":"Okumura","year":"2009","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib20","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1097\/MJT.0000000000000362","article-title":"The ocular hypotensive efficacy of topical Fasudil, a rho-associated protein kinase inhibitor, in patients with end-Stage glaucoma","volume":"24","author":"Pakravan","year":"2017","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.exer.2024.109977_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2020.12.006","article-title":"Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (ripasudil)","volume":"224","author":"Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109977_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00005-022-00642-z","article-title":"Rho kinases in embryonic development and stem cell research","volume":"70","author":"Shi","year":"2022","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.exer.2024.109977_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1167\/iovs.15-18300","article-title":"Predicative factors for corneal endothelial cell migration","volume":"57","author":"Soh","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib24","first-page":"1266","article-title":"A Rho-associated protein kinase: differentially distributed in limbal and corneal epithelia","volume":"39","author":"SundarRaj","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109977_bib25","first-page":"883","article-title":"An emerging treatment option for glaucoma: Rho kinase inhibitors","volume":"8","author":"Wang","year":"2014","journal-title":"Clin. Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:53:00Z","timestamp":1724374380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483524001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"alternative-id":["S0014483524001982"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.109977","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory exploration of the use of ripasudil in descemetorhexis with a human ex vivo model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.109977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109977"}}